As of 2025-03-18, the Relative Valuation of Amneal Pharmaceuticals Inc (AMRX) is (1.94) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.62 USD, the upside of Amneal Pharmaceuticals Inc based on Relative Valuation is -122.5%.
The range of the Relative Valuation is (1.67) - (2.00) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.9x - 28.7x | 26.1x |
| Forward P/E multiples | 20.4x - 24.6x | 21.6x |
| Fair Price | (1.67) - (2.00) | (1.94) |
| Upside | -119.3% - -123.3% | -122.5% |
| Date | P/E |
| 2025-02-18 | -95.62 |
| 2025-02-14 | -94.88 |
| 2025-02-13 | -97.09 |
| 2025-02-12 | -95.98 |
| 2025-02-11 | -97.70 |
| 2025-02-10 | -97.58 |
| 2025-02-07 | -96.35 |
| 2025-02-06 | -97.83 |
| 2025-02-05 | -97.95 |
| 2025-02-04 | -98.07 |
| 2025-02-03 | -100.40 |
| 2025-01-31 | -101.39 |
| 2025-01-30 | -105.31 |
| 2025-01-29 | -107.15 |
| 2025-01-28 | -107.15 |
| 2025-01-27 | -108.26 |
| 2025-01-24 | -106.54 |
| 2025-01-23 | -108.14 |
| 2025-01-22 | -104.58 |
| 2025-01-21 | -105.07 |
| 2025-01-17 | -101.39 |
| 2025-01-16 | -102.00 |
| 2025-01-15 | -100.89 |
| 2025-01-14 | -96.35 |
| 2025-01-13 | -94.76 |
| 2025-01-10 | -97.83 |
| 2025-01-08 | -98.93 |
| 2025-01-07 | -96.60 |
| 2025-01-06 | -95.37 |
| 2025-01-03 | -95.98 |
| 2025-01-02 | -95.25 |
| 2024-12-31 | -97.21 |
| 2024-12-30 | -96.11 |
| 2024-12-27 | -95.98 |
| 2024-12-26 | -96.35 |
| 2024-12-24 | -96.35 |
| 2024-12-23 | -95.62 |
| 2024-12-20 | -95.49 |
| 2024-12-19 | -95.13 |
| 2024-12-18 | -94.39 |
| 2024-12-17 | -99.05 |
| 2024-12-16 | -95.13 |
| 2024-12-13 | -96.11 |
| 2024-12-12 | -97.21 |
| 2024-12-11 | -99.42 |
| 2024-12-10 | -100.04 |
| 2024-12-09 | -99.30 |
| 2024-12-06 | -103.72 |
| 2024-12-05 | -105.93 |
| 2024-12-04 | -108.14 |